Hirasawa Takeshi

論文

Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing.

Pyogenic Spondylitis in Multidisciplinary Therapies of Gynecologic Malignancies: Three Cases Reports.

Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer.

Small Cell Neuroendocrine Carcinoma of the Endometrium with Difficulty Identifying the Original Site in the Uterus.

Hypoxia-inducible Factor-1α Suppression in Ovarian Clear-cell Carcinoma Cells by Silibinin Administration.

Utility of Comprehensive Serum Glycopeptide Spectra Analysis (CSGSA) for the Detection of Early Stage Epithelial Ovarian Cancer.

Comprehensive Serum Glycopeptide Spectra Analysis Combined with Artificial Intelligence (CSGSA-AI) to Diagnose Early-Stage Ovarian Cancer.

プラチナ感受性再発卵巣癌、腹膜癌、卵管癌におけるオラパリブの使用経験

共同研究・競争的資金等の研究課題

Development of hemodiagnosis for early detection of ovarian cancer with AI using glycopeptide peaks obtained from CSGSA (Comprehensive Serum Glycopeptide Spectra Analysis)

The vaginal microbiome in pathogenesis of endometriosis and endometriosis-related ovarian cancer

Development of hemodiagnosis for early detection of ovarian cancer using glycopeptide peaks obtained from CSGSA (Comprehensive Serum Glycopeptide Spectra Analysis)

Drug discovery and a new carcinogenic process in the clear cell adenocarcinoma of uterine body

Expression and Bio-function of Sugar chains in uterine endometrial adenocarcinoma, cervical carcinoma and uterine endometrium

Bio-function of glycolipids in uterine endometrial adencarcinoma and cervical carcinoma, and uterine endometrium